IL-22

IL-22 Informations sur la molécule

Nom anglaisInterleukin-22Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3Alias de la cibleIL-TIF,ZCYTO18,UNQ3099/PRO10096,ILTIF,Cytokine Zcyto18,IL-22,IL22,Interleukin 22,IL-10-Related T-Cell-Derived Inducible Factor,IL-10-Related T-Cell-Derived-Inducible Factor,Interleukin-22,TIFIL-23,IL-D110,TIFa,MGC79382,MGC79384
Phase de R&D la plus avancéePhase 3 Clinical
Nom anglaisInterleukin-22
Alias de la cibleIL-TIF,ZCYTO18,UNQ3099/PRO10096,ILTIF,Cytokine Zcyto18,IL-22,IL22,Interleukin 22,IL-10-Related T-Cell-Derived Inducible Factor,IL-10-Related T-Cell-Derived-Inducible Factor,Interleukin-22,TIFIL-23,IL-D110,TIFa,MGC79382,MGC79384
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques3
Phase de R&D la plus avancéePhase 3 Clinical

IL-22Contexte de la molécule

Interleukin-22 (IL22) is also known as cytokine Zcyto18, IL-10-related T-cell-derived-inducible factor (IL-TIF), which is belongs to the IL-10 family or IL-10 superfamily (including IL-19, IL-20, IL-24, and IL-26), a class of potent mediators of cellular inflammatory responses. IL-22 is produced by activated DC and T cells and initiates innate immune responses against bacterial pathogens especially in epithelial cells such as respiratory and gut epithelial cells. IL-22 biological activity is initiated by binding to a cell-surface complex composed of IL-22R1 and IL-10R2 receptor chains and further regulated by interactions with a soluble binding protein IL-22BP. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10.

IL-22Alias de la molécule

IL-22,IL-TIF,ZCYTO18

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Rose Bengal disodiumPV-10; PH-10Phase 3 ClinicalProvectusAcanthamoeba Keratitis; Breast Neoplasms; Candidiasis; Carcinoma, Hepatocellular; Cigarette Smoking; Colonic Neoplasms; Colorectal Neoplasms; Dermatitis, Atopic; Keratitis; Liver Neoplasms; Lung Neoplasms; Melanoma; Metastatic breast cancer; Neoplasm Metastasis; Neuroendocrine Tumors; Pancreatic Neoplasms; Plaque psoriasis; Psoriasis; Skin Melanoma; Uveal melanoma
Details
TemtokibartARGX-112; LEO-138559; LP-0145Phase 2 ClinicalArgenx Se, Leo Pharma IncDermatitis, Atopic
Details
AMT-126AMT-126Phase 1 ClinicalApplied Molecular Transport
Details

Avis sur les produits

  • V***s2025-07-19
    0Mettre un like
    We purchased the "Biotinylated Human IL-22 Protein, His,Avitag™" from ACRO Biosystems. The quality of this product is great and behaves as expected in our experiments. The product support is great and you can find all the information you need on the website. The only suggestion I would have for this is to make it easier and faster to get protocols and data sheets without having to enter all you basic information to be able to download them. Other than that the only other "negative" review I would have is that there are hardly any discounts or promotions for this product. We bought many of the 25ug vials and, in hindsight, we should have ordered the 200ug to be a little more cost effective. Other than that, communication with a representative is fast and easy if needed.
  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques